nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Fenethylline—Dimenhydrinate—atopic dermatitis	0.758	1	CrCrCtD
Pentoxifylline—Angioedema—Prednisolone—atopic dermatitis	0.000185	0.00099	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000183	0.000982	CcSEcCtD
Pentoxifylline—Pruritus—Tacrolimus—atopic dermatitis	0.000183	0.000979	CcSEcCtD
Pentoxifylline—Malaise—Prednisolone—atopic dermatitis	0.000182	0.000977	CcSEcCtD
Pentoxifylline—Dysgeusia—Triamcinolone—atopic dermatitis	0.000182	0.000976	CcSEcCtD
Pentoxifylline—Angioedema—Hydrocortisone—atopic dermatitis	0.000181	0.000967	CcSEcCtD
Pentoxifylline—Back pain—Triamcinolone—atopic dermatitis	0.00018	0.000964	CcSEcCtD
Pentoxifylline—Malaise—Hydrocortisone—atopic dermatitis	0.000178	0.000954	CcSEcCtD
Pentoxifylline—Diarrhoea—Tacrolimus—atopic dermatitis	0.000177	0.000947	CcSEcCtD
Pentoxifylline—Convulsion—Prednisolone—atopic dermatitis	0.000175	0.000939	CcSEcCtD
Pentoxifylline—Hypertension—Prednisolone—atopic dermatitis	0.000175	0.000935	CcSEcCtD
Pentoxifylline—Arrhythmia—Dexamethasone—atopic dermatitis	0.000173	0.000928	CcSEcCtD
Pentoxifylline—Arrhythmia—Betamethasone—atopic dermatitis	0.000173	0.000928	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000173	0.000924	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000172	0.000922	CcSEcCtD
Pentoxifylline—Convulsion—Hydrocortisone—atopic dermatitis	0.000171	0.000917	CcSEcCtD
Pentoxifylline—Dizziness—Tacrolimus—atopic dermatitis	0.000171	0.000915	CcSEcCtD
Pentoxifylline—Hypertension—Hydrocortisone—atopic dermatitis	0.000171	0.000914	CcSEcCtD
Pentoxifylline—Discomfort—Prednisolone—atopic dermatitis	0.00017	0.000911	CcSEcCtD
Pentoxifylline—Angioedema—Triamcinolone—atopic dermatitis	0.00017	0.00091	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisone—atopic dermatitis	0.00017	0.000909	CcSEcCtD
Pentoxifylline—Angioedema—Methylprednisolone—atopic dermatitis	0.00017	0.000908	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisone—atopic dermatitis	0.000169	0.000904	CcSEcCtD
Pentoxifylline—Erythema—Dexamethasone—atopic dermatitis	0.000169	0.000904	CcSEcCtD
Pentoxifylline—Erythema—Betamethasone—atopic dermatitis	0.000169	0.000904	CcSEcCtD
Pentoxifylline—Myalgia—Hydrocortisone—atopic dermatitis	0.000168	0.000901	CcSEcCtD
Pentoxifylline—Malaise—Triamcinolone—atopic dermatitis	0.000168	0.000899	CcSEcCtD
Pentoxifylline—Anxiety—Hydrocortisone—atopic dermatitis	0.000168	0.000898	CcSEcCtD
Pentoxifylline—Malaise—Methylprednisolone—atopic dermatitis	0.000167	0.000897	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000167	0.000895	CcSEcCtD
Pentoxifylline—Discomfort—Hydrocortisone—atopic dermatitis	0.000166	0.00089	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000165	0.000884	CcSEcCtD
Pentoxifylline—Oedema—Prednisolone—atopic dermatitis	0.000165	0.000884	CcSEcCtD
Pentoxifylline—Vomiting—Tacrolimus—atopic dermatitis	0.000164	0.00088	CcSEcCtD
Pentoxifylline—Rash—Tacrolimus—atopic dermatitis	0.000163	0.000873	CcSEcCtD
Pentoxifylline—Dermatitis—Tacrolimus—atopic dermatitis	0.000163	0.000872	CcSEcCtD
Pentoxifylline—Shock—Prednisolone—atopic dermatitis	0.000162	0.00087	CcSEcCtD
Pentoxifylline—Headache—Tacrolimus—atopic dermatitis	0.000162	0.000867	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000161	0.000864	CcSEcCtD
Pentoxifylline—Oedema—Hydrocortisone—atopic dermatitis	0.000161	0.000864	CcSEcCtD
Pentoxifylline—Convulsion—Triamcinolone—atopic dermatitis	0.000161	0.000863	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisolone—atopic dermatitis	0.000161	0.000863	CcSEcCtD
Pentoxifylline—Convulsion—Methylprednisolone—atopic dermatitis	0.000161	0.000861	CcSEcCtD
Pentoxifylline—Hypertension—Triamcinolone—atopic dermatitis	0.000161	0.00086	CcSEcCtD
Pentoxifylline—Hypertension—Methylprednisolone—atopic dermatitis	0.00016	0.000858	CcSEcCtD
Pentoxifylline—Infection—Hydrocortisone—atopic dermatitis	0.00016	0.000858	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00016	0.000855	CcSEcCtD
Pentoxifylline—Shock—Hydrocortisone—atopic dermatitis	0.000159	0.00085	CcSEcCtD
Pentoxifylline—Myalgia—Triamcinolone—atopic dermatitis	0.000158	0.000848	CcSEcCtD
Pentoxifylline—Myalgia—Methylprednisolone—atopic dermatitis	0.000158	0.000846	CcSEcCtD
Pentoxifylline—Anxiety—Methylprednisolone—atopic dermatitis	0.000158	0.000843	CcSEcCtD
Pentoxifylline—Tachycardia—Hydrocortisone—atopic dermatitis	0.000157	0.000843	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000157	0.000841	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—atopic dermatitis	0.000157	0.000839	CcSEcCtD
Pentoxifylline—Skin disorder—Hydrocortisone—atopic dermatitis	0.000157	0.000839	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000157	0.000839	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000157	0.000839	CcSEcCtD
Pentoxifylline—Discomfort—Triamcinolone—atopic dermatitis	0.000157	0.000838	CcSEcCtD
Pentoxifylline—Discomfort—Methylprednisolone—atopic dermatitis	0.000156	0.000836	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000156	0.000835	CcSEcCtD
Pentoxifylline—Dry mouth—Triamcinolone—atopic dermatitis	0.000155	0.00083	CcSEcCtD
Pentoxifylline—Angioedema—Dexamethasone—atopic dermatitis	0.000154	0.000826	CcSEcCtD
Pentoxifylline—Angioedema—Betamethasone—atopic dermatitis	0.000154	0.000826	CcSEcCtD
Pentoxifylline—Anorexia—Hydrocortisone—atopic dermatitis	0.000154	0.000823	CcSEcCtD
Pentoxifylline—Nausea—Tacrolimus—atopic dermatitis	0.000154	0.000822	CcSEcCtD
Pentoxifylline—Confusional state—Methylprednisolone—atopic dermatitis	0.000153	0.000818	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—atopic dermatitis	0.000153	0.000817	CcSEcCtD
Pentoxifylline—Malaise—Dexamethasone—atopic dermatitis	0.000152	0.000815	CcSEcCtD
Pentoxifylline—Malaise—Betamethasone—atopic dermatitis	0.000152	0.000815	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000152	0.000813	CcSEcCtD
Pentoxifylline—Oedema—Triamcinolone—atopic dermatitis	0.000152	0.000813	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000152	0.000811	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—atopic dermatitis	0.000151	0.000808	CcSEcCtD
Pentoxifylline—Infection—Triamcinolone—atopic dermatitis	0.000151	0.000808	CcSEcCtD
Pentoxifylline—Hypotension—Hydrocortisone—atopic dermatitis	0.000151	0.000807	CcSEcCtD
Pentoxifylline—Infection—Methylprednisolone—atopic dermatitis	0.000151	0.000806	CcSEcCtD
Pentoxifylline—Shock—Triamcinolone—atopic dermatitis	0.000149	0.0008	CcSEcCtD
Pentoxifylline—Insomnia—Prednisolone—atopic dermatitis	0.000149	0.0008	CcSEcCtD
Pentoxifylline—Shock—Methylprednisolone—atopic dermatitis	0.000149	0.000798	CcSEcCtD
Pentoxifylline—Tachycardia—Triamcinolone—atopic dermatitis	0.000148	0.000794	CcSEcCtD
Pentoxifylline—Tachycardia—Methylprednisolone—atopic dermatitis	0.000148	0.000792	CcSEcCtD
Pentoxifylline—Skin disorder—Methylprednisolone—atopic dermatitis	0.000147	0.000788	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—atopic dermatitis	0.000147	0.000787	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000147	0.000787	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000147	0.000786	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000147	0.000784	CcSEcCtD
Pentoxifylline—Convulsion—Dexamethasone—atopic dermatitis	0.000146	0.000783	CcSEcCtD
Pentoxifylline—Convulsion—Betamethasone—atopic dermatitis	0.000146	0.000783	CcSEcCtD
Pentoxifylline—Insomnia—Hydrocortisone—atopic dermatitis	0.000146	0.000781	CcSEcCtD
Pentoxifylline—Hypertension—Dexamethasone—atopic dermatitis	0.000146	0.000781	CcSEcCtD
Pentoxifylline—Hypertension—Betamethasone—atopic dermatitis	0.000146	0.000781	CcSEcCtD
Pentoxifylline—Myalgia—Dexamethasone—atopic dermatitis	0.000144	0.00077	CcSEcCtD
Pentoxifylline—Myalgia—Betamethasone—atopic dermatitis	0.000144	0.00077	CcSEcCtD
Pentoxifylline—Anxiety—Betamethasone—atopic dermatitis	0.000143	0.000767	CcSEcCtD
Pentoxifylline—Anxiety—Dexamethasone—atopic dermatitis	0.000143	0.000767	CcSEcCtD
Pentoxifylline—Discomfort—Dexamethasone—atopic dermatitis	0.000142	0.00076	CcSEcCtD
Pentoxifylline—Discomfort—Betamethasone—atopic dermatitis	0.000142	0.00076	CcSEcCtD
Pentoxifylline—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000142	0.00076	CcSEcCtD
Pentoxifylline—Hypotension—Methylprednisolone—atopic dermatitis	0.000142	0.000758	CcSEcCtD
Pentoxifylline—Decreased appetite—Hydrocortisone—atopic dermatitis	0.00014	0.000751	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—atopic dermatitis	0.000139	0.000742	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000138	0.000741	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000138	0.000739	CcSEcCtD
Pentoxifylline—Oedema—Dexamethasone—atopic dermatitis	0.000138	0.000738	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000138	0.000738	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000138	0.000738	CcSEcCtD
Pentoxifylline—Oedema—Betamethasone—atopic dermatitis	0.000138	0.000738	CcSEcCtD
Pentoxifylline—Insomnia—Triamcinolone—atopic dermatitis	0.000137	0.000735	CcSEcCtD
Pentoxifylline—Insomnia—Methylprednisolone—atopic dermatitis	0.000137	0.000734	CcSEcCtD
Pentoxifylline—Infection—Dexamethasone—atopic dermatitis	0.000137	0.000733	CcSEcCtD
Pentoxifylline—Infection—Betamethasone—atopic dermatitis	0.000137	0.000733	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—atopic dermatitis	0.000136	0.00073	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisolone—atopic dermatitis	0.000136	0.000729	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—atopic dermatitis	0.000136	0.000728	CcSEcCtD
Pentoxifylline—Shock—Dexamethasone—atopic dermatitis	0.000136	0.000726	CcSEcCtD
Pentoxifylline—Shock—Betamethasone—atopic dermatitis	0.000136	0.000726	CcSEcCtD
Pentoxifylline—Dyspnoea—Triamcinolone—atopic dermatitis	0.000135	0.000725	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—atopic dermatitis	0.000135	0.000724	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000135	0.000722	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000135	0.000722	CcSEcCtD
Pentoxifylline—Tachycardia—Dexamethasone—atopic dermatitis	0.000135	0.00072	CcSEcCtD
Pentoxifylline—Tachycardia—Betamethasone—atopic dermatitis	0.000135	0.00072	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—atopic dermatitis	0.000134	0.000719	CcSEcCtD
Pentoxifylline—Dyspepsia—Triamcinolone—atopic dermatitis	0.000134	0.000716	CcSEcCtD
Pentoxifylline—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000133	0.000714	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000133	0.000713	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000133	0.000713	CcSEcCtD
Pentoxifylline—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000133	0.000712	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—atopic dermatitis	0.000133	0.00071	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000132	0.000706	CcSEcCtD
Pentoxifylline—Anorexia—Dexamethasone—atopic dermatitis	0.000131	0.000703	CcSEcCtD
Pentoxifylline—Anorexia—Betamethasone—atopic dermatitis	0.000131	0.000703	CcSEcCtD
Pentoxifylline—Urticaria—Prednisolone—atopic dermatitis	0.000131	0.000702	CcSEcCtD
Pentoxifylline—Hypotension—Betamethasone—atopic dermatitis	0.000129	0.000689	CcSEcCtD
Pentoxifylline—Hypotension—Dexamethasone—atopic dermatitis	0.000129	0.000689	CcSEcCtD
Pentoxifylline—Urticaria—Hydrocortisone—atopic dermatitis	0.000128	0.000686	CcSEcCtD
Pentoxifylline—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000128	0.000683	CcSEcCtD
Pentoxifylline—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000128	0.000683	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—atopic dermatitis	0.000127	0.000682	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—atopic dermatitis	0.000127	0.00068	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000126	0.000672	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000126	0.000672	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—atopic dermatitis	0.000125	0.00067	CcSEcCtD
Pentoxifylline—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000125	0.00067	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000125	0.000669	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—atopic dermatitis	0.000125	0.000668	CcSEcCtD
Pentoxifylline—Insomnia—Betamethasone—atopic dermatitis	0.000125	0.000667	CcSEcCtD
Pentoxifylline—Insomnia—Dexamethasone—atopic dermatitis	0.000125	0.000667	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000124	0.000666	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000124	0.000663	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—atopic dermatitis	0.000124	0.000662	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisolone—atopic dermatitis	0.000122	0.000651	CcSEcCtD
Pentoxifylline—Dyspepsia—Dexamethasone—atopic dermatitis	0.000121	0.000649	CcSEcCtD
Pentoxifylline—Dyspepsia—Betamethasone—atopic dermatitis	0.000121	0.000649	CcSEcCtD
Pentoxifylline—Urticaria—Triamcinolone—atopic dermatitis	0.000121	0.000646	CcSEcCtD
Pentoxifylline—Urticaria—Methylprednisolone—atopic dermatitis	0.00012	0.000645	CcSEcCtD
Pentoxifylline—Body temperature increased—Triamcinolone—atopic dermatitis	0.00012	0.000643	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—atopic dermatitis	0.00012	0.000643	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—atopic dermatitis	0.00012	0.000643	CcSEcCtD
Pentoxifylline—Abdominal pain—Methylprednisolone—atopic dermatitis	0.00012	0.000641	CcSEcCtD
Pentoxifylline—Decreased appetite—Dexamethasone—atopic dermatitis	0.00012	0.000641	CcSEcCtD
Pentoxifylline—Decreased appetite—Betamethasone—atopic dermatitis	0.00012	0.000641	CcSEcCtD
Pentoxifylline—Infection—Prednisone—atopic dermatitis	0.000119	0.000638	CcSEcCtD
Pentoxifylline—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000119	0.000636	CcSEcCtD
Pentoxifylline—Shock—Prednisone—atopic dermatitis	0.000118	0.000632	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—atopic dermatitis	0.000117	0.000627	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—atopic dermatitis	0.000117	0.000624	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—atopic dermatitis	0.000116	0.000621	CcSEcCtD
Pentoxifylline—Asthenia—Hydrocortisone—atopic dermatitis	0.000116	0.00062	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—atopic dermatitis	0.000114	0.000612	CcSEcCtD
Pentoxifylline—Pruritus—Hydrocortisone—atopic dermatitis	0.000114	0.000611	CcSEcCtD
Pentoxifylline—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000114	0.000608	CcSEcCtD
Pentoxifylline—Feeling abnormal—Betamethasone—atopic dermatitis	0.000114	0.000608	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL11—atopic dermatitis	0.000113	0.00204	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FCER2—atopic dermatitis	0.000113	0.00204	CbGpPWpGaD
Pentoxifylline—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000113	0.000603	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000113	0.000603	CcSEcCtD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000112	0.00202	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL22—atopic dermatitis	0.000112	0.00202	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000112	0.000599	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—NGF—atopic dermatitis	0.000112	0.00201	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000112	0.000598	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—FCER2—atopic dermatitis	0.000112	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CCL5—atopic dermatitis	0.000111	0.002	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00011	0.000591	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL27—atopic dermatitis	0.00011	0.00199	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCR3—atopic dermatitis	0.00011	0.00198	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCR3—atopic dermatitis	0.00011	0.00198	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL17—atopic dermatitis	0.00011	0.00198	CbGpPWpGaD
Pentoxifylline—Urticaria—Betamethasone—atopic dermatitis	0.000109	0.000586	CcSEcCtD
Pentoxifylline—Urticaria—Dexamethasone—atopic dermatitis	0.000109	0.000586	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000109	0.000585	CcSEcCtD
Pentoxifylline—Dizziness—Prednisolone—atopic dermatitis	0.000109	0.000585	CcSEcCtD
Pentoxifylline—Asthenia—Triamcinolone—atopic dermatitis	0.000109	0.000583	CcSEcCtD
Pentoxifylline—Body temperature increased—Dexamethasone—atopic dermatitis	0.000109	0.000583	CcSEcCtD
Pentoxifylline—Body temperature increased—Betamethasone—atopic dermatitis	0.000109	0.000583	CcSEcCtD
Pentoxifylline—Abdominal pain—Betamethasone—atopic dermatitis	0.000109	0.000583	CcSEcCtD
Pentoxifylline—Abdominal pain—Dexamethasone—atopic dermatitis	0.000109	0.000583	CcSEcCtD
Pentoxifylline—Asthenia—Methylprednisolone—atopic dermatitis	0.000109	0.000582	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—atopic dermatitis	0.000109	0.000581	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR downstream signaling—NPS—atopic dermatitis	0.000108	0.00194	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—TAC1—atopic dermatitis	0.000108	0.00194	CbGpPWpGaD
Pentoxifylline—Pruritus—Triamcinolone—atopic dermatitis	0.000107	0.000575	CcSEcCtD
Pentoxifylline—Pruritus—Methylprednisolone—atopic dermatitis	0.000107	0.000574	CcSEcCtD
Pentoxifylline—Dizziness—Hydrocortisone—atopic dermatitis	0.000107	0.000571	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000106	0.00191	CbGpPWpGaD
Pentoxifylline—Dyspepsia—Prednisone—atopic dermatitis	0.000106	0.000566	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—CCL22—atopic dermatitis	0.000105	0.00189	CbGpPWpGaD
Pentoxifylline—Decreased appetite—Prednisone—atopic dermatitis	0.000104	0.000559	CcSEcCtD
Pentoxifylline—Rash—Prednisolone—atopic dermatitis	0.000104	0.000558	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisolone—atopic dermatitis	0.000104	0.000557	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—CCL22—atopic dermatitis	0.000104	0.00187	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000104	0.000555	CcSEcCtD
Pentoxifylline—Headache—Prednisolone—atopic dermatitis	0.000103	0.000554	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000103	0.00185	CbGpPWpGaD
Pentoxifylline—Constipation—Prednisone—atopic dermatitis	0.000103	0.000549	CcSEcCtD
Pentoxifylline—Vomiting—Hydrocortisone—atopic dermatitis	0.000103	0.000549	CcSEcCtD
Pentoxifylline—Rash—Hydrocortisone—atopic dermatitis	0.000102	0.000545	CcSEcCtD
Pentoxifylline—Dermatitis—Hydrocortisone—atopic dermatitis	0.000102	0.000544	CcSEcCtD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR3—atopic dermatitis	0.000102	0.00183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000101	0.00182	CbGpPWpGaD
Pentoxifylline—Headache—Hydrocortisone—atopic dermatitis	0.000101	0.000541	CcSEcCtD
Pentoxifylline—Dizziness—Triamcinolone—atopic dermatitis	0.0001	0.000538	CcSEcCtD
Pentoxifylline—Dizziness—Methylprednisolone—atopic dermatitis	0.0001	0.000537	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL5—atopic dermatitis	0.0001	0.00181	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL27—atopic dermatitis	9.99e-05	0.0018	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR3—atopic dermatitis	9.97e-05	0.0018	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CCR5—atopic dermatitis	9.97e-05	0.0018	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—CXCL8—atopic dermatitis	9.95e-05	0.0018	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCL10—atopic dermatitis	9.92e-05	0.00179	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—MAPK8—atopic dermatitis	9.92e-05	0.00179	CbGpPWpGaD
Pentoxifylline—Feeling abnormal—Prednisone—atopic dermatitis	9.89e-05	0.000529	CcSEcCtD
Pentoxifylline—Asthenia—Dexamethasone—atopic dermatitis	9.89e-05	0.000529	CcSEcCtD
Pentoxifylline—Asthenia—Betamethasone—atopic dermatitis	9.89e-05	0.000529	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL17—atopic dermatitis	9.87e-05	0.00178	CbGpPWpGaD
Pentoxifylline—Gastrointestinal pain—Prednisone—atopic dermatitis	9.81e-05	0.000525	CcSEcCtD
Pentoxifylline—Nausea—Prednisolone—atopic dermatitis	9.81e-05	0.000525	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—NPS—atopic dermatitis	9.79e-05	0.00177	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—TAC1—atopic dermatitis	9.79e-05	0.00177	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—TAC1—atopic dermatitis	9.79e-05	0.00177	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—NPS—atopic dermatitis	9.79e-05	0.00177	CbGpPWpGaD
Pentoxifylline—Pruritus—Betamethasone—atopic dermatitis	9.75e-05	0.000522	CcSEcCtD
Pentoxifylline—Pruritus—Dexamethasone—atopic dermatitis	9.75e-05	0.000522	CcSEcCtD
Pentoxifylline—Vomiting—Triamcinolone—atopic dermatitis	9.66e-05	0.000517	CcSEcCtD
Pentoxifylline—Vomiting—Methylprednisolone—atopic dermatitis	9.64e-05	0.000516	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCR3—atopic dermatitis	9.6e-05	0.00173	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCR3—atopic dermatitis	9.6e-05	0.00173	CbGpPWpGaD
Pentoxifylline—Nausea—Hydrocortisone—atopic dermatitis	9.58e-05	0.000513	CcSEcCtD
Pentoxifylline—Rash—Triamcinolone—atopic dermatitis	9.58e-05	0.000513	CcSEcCtD
Pentoxifylline—Dermatitis—Triamcinolone—atopic dermatitis	9.57e-05	0.000512	CcSEcCtD
Pentoxifylline—Rash—Methylprednisolone—atopic dermatitis	9.56e-05	0.000512	CcSEcCtD
Pentoxifylline—Dermatitis—Methylprednisolone—atopic dermatitis	9.55e-05	0.000511	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—atopic dermatitis	9.53e-05	0.00051	CcSEcCtD
Pentoxifylline—Headache—Triamcinolone—atopic dermatitis	9.52e-05	0.000509	CcSEcCtD
Pentoxifylline—Headache—Methylprednisolone—atopic dermatitis	9.49e-05	0.000508	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—atopic dermatitis	9.49e-05	0.000508	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—atopic dermatitis	9.49e-05	0.000508	CcSEcCtD
Pentoxifylline—Diarrhoea—Dexamethasone—atopic dermatitis	9.43e-05	0.000505	CcSEcCtD
Pentoxifylline—Diarrhoea—Betamethasone—atopic dermatitis	9.43e-05	0.000505	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—CCL27—atopic dermatitis	9.36e-05	0.00169	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR3—atopic dermatitis	9.34e-05	0.00168	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	9.31e-05	0.00168	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL27—atopic dermatitis	9.25e-05	0.00167	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR3—atopic dermatitis	9.22e-05	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NFKBIA—atopic dermatitis	9.21e-05	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—NPS—atopic dermatitis	9.16e-05	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—TAC1—atopic dermatitis	9.16e-05	0.00165	CbGpPWpGaD
Pentoxifylline—Dizziness—Betamethasone—atopic dermatitis	9.11e-05	0.000488	CcSEcCtD
Pentoxifylline—Dizziness—Dexamethasone—atopic dermatitis	9.11e-05	0.000488	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL5—atopic dermatitis	9.1e-05	0.00164	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL5—atopic dermatitis	9.1e-05	0.00164	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—IL2—atopic dermatitis	9.08e-05	0.00164	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—TAC1—atopic dermatitis	9.05e-05	0.00163	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—NPS—atopic dermatitis	9.05e-05	0.00163	CbGpPWpGaD
Pentoxifylline—Nausea—Triamcinolone—atopic dermatitis	9.02e-05	0.000483	CcSEcCtD
Pentoxifylline—Nausea—Methylprednisolone—atopic dermatitis	9e-05	0.000482	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCR3—atopic dermatitis	8.99e-05	0.00162	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL17—atopic dermatitis	8.96e-05	0.00162	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NPS—atopic dermatitis	8.89e-05	0.0016	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—TAC1—atopic dermatitis	8.89e-05	0.0016	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCR3—atopic dermatitis	8.88e-05	0.0016	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Prednisone—atopic dermatitis	8.84e-05	0.000473	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL11—atopic dermatitis	8.84e-05	0.0016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KIF3A—atopic dermatitis	8.8e-05	0.00159	CbGpPWpGaD
Pentoxifylline—Vomiting—Dexamethasone—atopic dermatitis	8.76e-05	0.000469	CcSEcCtD
Pentoxifylline—Vomiting—Betamethasone—atopic dermatitis	8.76e-05	0.000469	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling Pathways—FCER2—atopic dermatitis	8.72e-05	0.00157	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCR3—atopic dermatitis	8.71e-05	0.00157	CbGpPWpGaD
Pentoxifylline—Rash—Dexamethasone—atopic dermatitis	8.69e-05	0.000465	CcSEcCtD
Pentoxifylline—Rash—Betamethasone—atopic dermatitis	8.69e-05	0.000465	CcSEcCtD
Pentoxifylline—Dermatitis—Dexamethasone—atopic dermatitis	8.68e-05	0.000465	CcSEcCtD
Pentoxifylline—Dermatitis—Betamethasone—atopic dermatitis	8.68e-05	0.000465	CcSEcCtD
Pentoxifylline—Headache—Betamethasone—atopic dermatitis	8.63e-05	0.000462	CcSEcCtD
Pentoxifylline—Headache—Dexamethasone—atopic dermatitis	8.63e-05	0.000462	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—atopic dermatitis	8.61e-05	0.000461	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCL5—atopic dermatitis	8.54e-05	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCL10—atopic dermatitis	8.54e-05	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL5—atopic dermatitis	8.52e-05	0.00154	CbGpPWpGaD
Pentoxifylline—Pruritus—Prednisone—atopic dermatitis	8.49e-05	0.000455	CcSEcCtD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	8.46e-05	0.00153	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL5—atopic dermatitis	8.42e-05	0.00152	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL17—atopic dermatitis	8.39e-05	0.00151	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NPS—atopic dermatitis	8.32e-05	0.0015	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—TAC1—atopic dermatitis	8.32e-05	0.0015	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL17—atopic dermatitis	8.29e-05	0.0015	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL5—atopic dermatitis	8.26e-05	0.00149	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NPS—atopic dermatitis	8.22e-05	0.00148	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—TAC1—atopic dermatitis	8.22e-05	0.00148	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Prednisone—atopic dermatitis	8.21e-05	0.00044	CcSEcCtD
Pentoxifylline—Nausea—Betamethasone—atopic dermatitis	8.19e-05	0.000438	CcSEcCtD
Pentoxifylline—Nausea—Dexamethasone—atopic dermatitis	8.19e-05	0.000438	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCR3—atopic dermatitis	8.16e-05	0.00147	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL22—atopic dermatitis	8.11e-05	0.00146	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCR3—atopic dermatitis	8.06e-05	0.00145	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PPARA—atopic dermatitis	8.06e-05	0.00145	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KIF3A—atopic dermatitis	7.99e-05	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CMA1—atopic dermatitis	7.96e-05	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL11—atopic dermatitis	7.96e-05	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR3—atopic dermatitis	7.94e-05	0.00143	CbGpPWpGaD
Pentoxifylline—Dizziness—Prednisone—atopic dermatitis	7.94e-05	0.000425	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.91e-05	0.00143	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL10—atopic dermatitis	7.76e-05	0.0014	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL10—atopic dermatitis	7.76e-05	0.0014	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL5—atopic dermatitis	7.74e-05	0.0014	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	7.71e-05	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CCR5—atopic dermatitis	7.7e-05	0.00139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—MAPK8—atopic dermatitis	7.66e-05	0.00138	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL5—atopic dermatitis	7.64e-05	0.00138	CbGpPWpGaD
Pentoxifylline—Vomiting—Prednisone—atopic dermatitis	7.63e-05	0.000409	CcSEcCtD
Pentoxifylline—Rash—Prednisone—atopic dermatitis	7.57e-05	0.000405	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—atopic dermatitis	7.56e-05	0.000405	CcSEcCtD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	7.54e-05	0.00136	CbGpPWpGaD
Pentoxifylline—Headache—Prednisone—atopic dermatitis	7.52e-05	0.000403	CcSEcCtD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	7.51e-05	0.00136	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT6—atopic dermatitis	7.48e-05	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KIF3A—atopic dermatitis	7.48e-05	0.00135	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KIF3A—atopic dermatitis	7.39e-05	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CCL5—atopic dermatitis	7.35e-05	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL10—atopic dermatitis	7.26e-05	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL27—atopic dermatitis	7.22e-05	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CMA1—atopic dermatitis	7.22e-05	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL11—atopic dermatitis	7.22e-05	0.0013	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR3—atopic dermatitis	7.21e-05	0.0013	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL10—atopic dermatitis	7.18e-05	0.00129	CbGpPWpGaD
Pentoxifylline—Nausea—Prednisone—atopic dermatitis	7.13e-05	0.000382	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCL8—atopic dermatitis	7.09e-05	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—NPS—atopic dermatitis	7.07e-05	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—TAC1—atopic dermatitis	7.07e-05	0.00128	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL10—atopic dermatitis	7.04e-05	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	6.94e-05	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT6—atopic dermatitis	6.79e-05	0.00123	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CMA1—atopic dermatitis	6.77e-05	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL11—atopic dermatitis	6.77e-05	0.00122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL11—atopic dermatitis	6.68e-05	0.00121	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CMA1—atopic dermatitis	6.68e-05	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCL5—atopic dermatitis	6.68e-05	0.0012	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCL5—atopic dermatitis	6.68e-05	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CCR5—atopic dermatitis	6.62e-05	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL10—atopic dermatitis	6.6e-05	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL5—atopic dermatitis	6.58e-05	0.00119	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL10—atopic dermatitis	6.52e-05	0.00118	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR3—atopic dermatitis	6.49e-05	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL17—atopic dermatitis	6.48e-05	0.00117	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—TAC1—atopic dermatitis	6.42e-05	0.00116	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NPS—atopic dermatitis	6.42e-05	0.00116	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT6—atopic dermatitis	6.36e-05	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—atopic dermatitis	6.34e-05	0.00114	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCR3—atopic dermatitis	6.3e-05	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT6—atopic dermatitis	6.29e-05	0.00113	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCL5—atopic dermatitis	6.25e-05	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCL5—atopic dermatitis	6.18e-05	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.11e-05	0.0011	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCL5—atopic dermatitis	6.06e-05	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCL8—atopic dermatitis	6.03e-05	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CCR5—atopic dermatitis	6.02e-05	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CCR5—atopic dermatitis	6.02e-05	0.00109	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL5—atopic dermatitis	5.97e-05	0.00108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR3—atopic dermatitis	5.89e-05	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NPS—atopic dermatitis	5.78e-05	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TAC1—atopic dermatitis	5.78e-05	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—MAPK8—atopic dermatitis	5.78e-05	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KIF3A—atopic dermatitis	5.78e-05	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL5—atopic dermatitis	5.68e-05	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCR3—atopic dermatitis	5.67e-05	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CCR5—atopic dermatitis	5.63e-05	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL5—atopic dermatitis	5.61e-05	0.00101	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	5.61e-05	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CCR5—atopic dermatitis	5.57e-05	0.001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR3—atopic dermatitis	5.51e-05	0.000995	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	5.47e-05	0.000988	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	5.47e-05	0.000988	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CCR5—atopic dermatitis	5.46e-05	0.000986	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR3—atopic dermatitis	5.45e-05	0.000983	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL5—atopic dermatitis	5.37e-05	0.00097	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TAC1—atopic dermatitis	5.25e-05	0.000947	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NPS—atopic dermatitis	5.25e-05	0.000947	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL11—atopic dermatitis	5.22e-05	0.000942	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CMA1—atopic dermatitis	5.22e-05	0.000942	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCR3—atopic dermatitis	5.15e-05	0.000929	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	5.14e-05	0.000927	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCR5—atopic dermatitis	5.12e-05	0.000923	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL10—atopic dermatitis	5.09e-05	0.000919	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCR5—atopic dermatitis	5.05e-05	0.000912	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NPS—atopic dermatitis	4.92e-05	0.000887	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TAC1—atopic dermatitis	4.92e-05	0.000887	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT6—atopic dermatitis	4.91e-05	0.000886	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—atopic dermatitis	4.89e-05	0.000883	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL5—atopic dermatitis	4.88e-05	0.000881	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TAC1—atopic dermatitis	4.86e-05	0.000876	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NPS—atopic dermatitis	4.86e-05	0.000876	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCL5—atopic dermatitis	4.83e-05	0.000871	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCR3—atopic dermatitis	4.82e-05	0.00087	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	4.8e-05	0.000865	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCR3—atopic dermatitis	4.76e-05	0.000859	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCL8—atopic dermatitis	4.65e-05	0.00084	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL10—atopic dermatitis	4.58e-05	0.000827	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL5—atopic dermatitis	4.57e-05	0.000825	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL5—atopic dermatitis	4.52e-05	0.000815	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL5—atopic dermatitis	4.38e-05	0.000791	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CCR5—atopic dermatitis	4.35e-05	0.000785	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR3—atopic dermatitis	4.26e-05	0.000768	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL10—atopic dermatitis	4.16e-05	0.000751	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	4.01e-05	0.000723	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR5—atopic dermatitis	3.95e-05	0.000713	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL5—atopic dermatitis	3.94e-05	0.000712	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL10—atopic dermatitis	3.9e-05	0.000703	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL10—atopic dermatitis	3.85e-05	0.000695	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—IL2—atopic dermatitis	3.83e-05	0.000691	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NPS—atopic dermatitis	3.8e-05	0.000685	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TAC1—atopic dermatitis	3.8e-05	0.000685	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCR3—atopic dermatitis	3.72e-05	0.000672	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—atopic dermatitis	3.69e-05	0.000666	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGF—atopic dermatitis	3.65e-05	0.000659	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL8—atopic dermatitis	3.64e-05	0.000656	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.64e-05	0.000656	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL5—atopic dermatitis	3.58e-05	0.000646	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR5—atopic dermatitis	3.55e-05	0.000641	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL5—atopic dermatitis	3.53e-05	0.000637	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL2—atopic dermatitis	3.48e-05	0.000627	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—IL2—atopic dermatitis	3.48e-05	0.000627	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.41e-05	0.000614	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.37e-05	0.000607	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL5—atopic dermatitis	3.35e-05	0.000605	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGF—atopic dermatitis	3.32e-05	0.000599	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL5—atopic dermatitis	3.31e-05	0.000598	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL8—atopic dermatitis	3.3e-05	0.000596	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—IL2—atopic dermatitis	3.25e-05	0.000587	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR5—atopic dermatitis	3.23e-05	0.000582	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—IL2—atopic dermatitis	3.22e-05	0.00058	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL2—atopic dermatitis	3.16e-05	0.000569	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGF—atopic dermatitis	3.11e-05	0.00056	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—atopic dermatitis	3.09e-05	0.000558	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGF—atopic dermatitis	3.07e-05	0.000554	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—atopic dermatitis	3.06e-05	0.000551	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR5—atopic dermatitis	3.02e-05	0.000545	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NFKBIA—atopic dermatitis	3.01e-05	0.000544	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL10—atopic dermatitis	3.01e-05	0.000543	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR5—atopic dermatitis	2.99e-05	0.000539	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL2—atopic dermatitis	2.96e-05	0.000533	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL2—atopic dermatitis	2.92e-05	0.000527	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NFKBIA—atopic dermatitis	2.74e-05	0.000494	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.63e-05	0.000474	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL5—atopic dermatitis	2.59e-05	0.000467	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NFKBIA—atopic dermatitis	2.56e-05	0.000462	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NFKBIA—atopic dermatitis	2.53e-05	0.000457	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—IL2—atopic dermatitis	2.51e-05	0.000453	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGF—atopic dermatitis	2.4e-05	0.000433	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.39e-05	0.000431	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR5—atopic dermatitis	2.33e-05	0.000421	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GLB1—atopic dermatitis	2.29e-05	0.000413	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL2—atopic dermatitis	2.28e-05	0.000412	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADSL—atopic dermatitis	2.19e-05	0.000396	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—atopic dermatitis	2.15e-05	0.000388	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL2—atopic dermatitis	2.05e-05	0.00037	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—atopic dermatitis	2.04e-05	0.000369	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NFKBIA—atopic dermatitis	1.98e-05	0.000357	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—atopic dermatitis	1.95e-05	0.000352	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MAPK8—atopic dermatitis	1.89e-05	0.000341	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL2—atopic dermatitis	1.86e-05	0.000336	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—atopic dermatitis	1.86e-05	0.000335	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—atopic dermatitis	1.83e-05	0.00033	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—atopic dermatitis	1.81e-05	0.000326	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL2—atopic dermatitis	1.75e-05	0.000315	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—atopic dermatitis	1.74e-05	0.000313	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL2—atopic dermatitis	1.73e-05	0.000311	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—atopic dermatitis	1.72e-05	0.00031	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MAPK8—atopic dermatitis	1.72e-05	0.00031	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.67e-05	0.000301	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MAPK8—atopic dermatitis	1.61e-05	0.00029	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MAPK8—atopic dermatitis	1.59e-05	0.000287	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—atopic dermatitis	1.41e-05	0.000255	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL2—atopic dermatitis	1.35e-05	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—atopic dermatitis	1.34e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.24e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—atopic dermatitis	1.21e-05	0.000218	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—atopic dermatitis	1.1e-05	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—atopic dermatitis	1.03e-05	0.000185	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—atopic dermatitis	1.01e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—atopic dermatitis	7.92e-06	0.000143	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARA—atopic dermatitis	7.42e-06	0.000134	CbGpPWpGaD
